A Lack of Biomarkers for Cardiac Complications of Immune Checkpoint Inhibitor Therapy

Intern Med. 2021 Feb 1;60(3):325-326. doi: 10.2169/internalmedicine.5962-20. Epub 2020 Sep 19.
No abstract available

Keywords: cytokine; immune checkpoint inhibitor; immune-related adverse event; myocarditis.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Immunological* / adverse effects
  • Biomarkers
  • Cytokines
  • Humans
  • Immune Checkpoint Inhibitors*
  • Nivolumab / adverse effects

Substances

  • Antineoplastic Agents, Immunological
  • Biomarkers
  • Cytokines
  • Immune Checkpoint Inhibitors
  • Nivolumab